| Stage | TMO | % of rev | ROK | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $12.1B | 100.00% | $2.3B | 100.00% | TMO ×5.25 |
| Gross profit | $5.1B | 42.28% | $1.1B | 49.46% | ROK +7.2pp |
| Operating income | $2.3B | 18.65% | $481M | 20.80% | ROK +2.2pp |
| Pre-tax income | $2.1B | 17.20% | $470M | 20.32% | ROK +3.1pp |
| Net income | $1.7B | 14.23% | $408M | 17.64% | ROK +3.4pp |
| Stage | TMO | ROK | Gap · A − B |
|---|---|---|---|
| Revenue | $12.1B100.00% | $2.3B100.00% | TMO ×5.25 |
| Gross profit | 42.28%$5.1B | 49.46%$1.1B | ROK +7.2pp |
| Operating income | 18.65%$2.3B | 20.80%$481M | ROK +2.2pp |
| Pre-tax income | 17.20%$2.1B | 20.32%$470M | ROK +3.1pp |
| Net income |
| 14.23%$1.7B |
| 17.64%$408M |
| ROK +3.4pp |
No shared counterparties.